Abstract
Introduction: Predictive factors for the treatment success of low-intensity extracorporeal shockwave therapy (Li-ESWT) for erectile dysfunction (ED) are still under debate. Methods: Li-ESWT was performed in 50 patients suffering from ED by applying 3,000 shock waves once a week over a period of 6 weeks. Treatment success was defined as an increase in the International Index of Erectile Function 5 (IIEF-5) score by ≥5 points or an Erectile Hardness Score (EHS) of ≥3 points. IIEF-5 and EHS were measured at baseline and at 3 and 6 months of follow-up. Results: Treatment success according to either the IIEF-5 score or EHS at any time of follow-up was achieved in 28 patients (56%). Twenty-five patients (50%) experienced an improvement during the first 3 months, which lasted for 6 months in 8 cases (16%). Three patients reported improved erectile function only after 6 months. When stratifying the cohort with regard to potential influencing factors, a significantly improved IIEF-5 score could be achieved in men with cardiovascular risk factors (p = 0.026) and in men with antihypertensive medication (p = 0.009). Men without cardiovascular risk factors showed no therapeutic benefit from Li-ESWT. Discussion/Conclusion: Li-ESWT is a valid but often short-lived treatment option for ED, especially in men with cardiovascular risk factors or controlled hypertension. Future studies should assess the feasibility and safety of repeated applications of Li-ESWT.
References
1.
Türk
C
, Petřík
A
, Sarica
K
, Seitz
C
, Skolarikos
A
, Straub
M
, EAU guidelines on interventional treatment for urolithiasis
. Eur Urol
. 2016 Mar
;69
(3
):475
–82
.2.
Vardi
Y
, Appel
B
, Jacob
G
, Massarwi
O
, Gruenwald
I
. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction
. Eur Urol
. 2010
;58
(2
):243
–8
. .3.
Qiu
X
, Lin
G
, Xin
Z
, Ferretti
L
, Zhang
H
, Lue
TF
, Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model
. J Sex Med
. 2013
;10
(3
):738
–46
.4.
Fode
M
, Fode
M
, Hatzichristodoulou
G
, Serefoglu
EC
, Verze
P
, Albersen
M
. Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?
Nat Rev Urol
. 2017
;14
(10
):593
–606
. .5.
Katz
JE
, Clavijo
RI
, Rizk
P
, Ramasamy
R
. The basic physics of waves, soundwaves, and shockwaves for erectile dysfunction
. Sex Med Rev
. 2020
;8
(1
):100
–5
. .6.
Gruenwald
I
, Kitrey
ND
, Appel
B
, Vardi
Y
. Low-intensity extracorporeal shock wave therapy in vascular disease and erectile dysfunction: theory and outcomes
. Sex Med Rev
. 2013
;1
(2
):83
–90
. .7.
Sokolakis
I
, Dimitriadis
F
, Teo
P
, Hatzichristodoulou
G
, Hatzichristou
D
, Giuliano
F
. The basic science behind low-intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic scoping review of pre-clinical studies
. J Sex Med
. 2019
;16
(2
):168
–94
. .8.
Scroppo
FI
, Pezzoni
F
, Gaeta
F
, Pastore
LA
, Malfatto
M
, Cai
T
, Li-Eswt improves hemodynamic parameters thus suggesting neoangiogenesis in patients with vascular erectile dysfunction
. Int J Impot Res
. 2021
. Epub ahead of print.9.
Kendirci
M
, Tanriverdi
O
, Trost
L
, Hellstrom
WJ
. Management of sildenafil treatment failures
. Curr Opin Urol
. 2006
;16
(6
):449
–59
. .10.
Vardi
Y
, Appel
B
, Kilchevsky
A
, Gruenwald
I
. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study
. J Urol
. 2012
;187
(5
):1769
–75
. .11.
Capogrosso
P
, Colicchia
M
, Ventimiglia
E
, Castagna
G
, Clementi
MC
, Suardi
N
, One patient out of four with newly diagnosed erectile dysfunction is a young man: worrisome picture from the everyday clinical practice
. J Sex Med
. 2013
;10
(7
):1833
–41
.12.
Chung
E
, Cartmill
R
. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial
. BJU Int
. 2015
;115
(Suppl 5
):46
–9
. .13.
Olsen
AB
, Persiani
M
, Boie
S
, Hanna
M
, Lund
L
. Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study
. Scand J Urol
. 2015
;49
(4
):329
–33
. .14.
Rosen
RC
, Cappelleri
JC
, Smith
MD
, Lipsky
J
, Peña
BM
. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction
. Int J Impot Res
. 1999
;11
(6
):319
–26
. .15.
Rosen
RC
, Allen
KR
, Ni
X
, Araujo
AB
. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale
. Eur Urol
. 2011
;60
(5
):1010
–6
. .16.
Mulhall
JP
, Goldstein
I
, Bushmakin
AG
, Cappelleri
JC
, Hvidsten
K
. Validation of the erection hardness score
. J Sex Med
. 2007
;4
(6
):1626
–34
. .17.
Heinemann
LAJ
, Zimmermann
T
, Vermeulen
A
, Thiel
C
, Hummel
W
. A new “aging males” symptoms’ rating scale
. Aging Male
. 1999
;2
(2
):105
–14
. .18.
Daig
I
, Heinemann
LAJ
, Kim
S
, Leungwattanakij
S
, Badia
X
, Myon
E
, The Aging Males’ Symptoms (AMS) scale: review of its methodological characteristics
. Health Qual Life Outcomes
. 2003
;1
:77
.19.
Heinemann
LA
, Moore
C
, Dinger
JC
, Stoehr
D
. Sensitivity as outcome measure of androgen replacement: the AMS scale
. Health Qual Life Outcomes
. 2006
;4
:23
. .20.
Hatzimouratidis
K
, Amar
E
, Eardley
I
, Giuliano
F
, Hatzichristou
D
, Montorsi
F
, Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation
. Eur Urol
. 2010
;57
(5
):804
–14
.21.
McCabe
MP
, Sharlip
ID
, Atalla
E
, Balon
R
, Fisher
AD
, Laumann
E
, Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015
. J Sex Med
. 2016
;13
(2
):135
–43
.22.
Valladales-Restrepo
LF
, Machado-Alba
JE
. Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction
. Int J Clin Pharm
. 2021
;43
(4
):900
–8
.23.
Rhim
HC
, Kim
MS
, Park
YJ
, Choi
WS
, Park
HK
, Kim
HG
, The potential role of arginine supplements on erectile dysfunction: a systemic review and meta-analysis
. J Sex Med
. 2019
;16
(2
):223
–34
.24.
Demirci
A
, Çakan
M
, Topçuoğlu
M
. Whether adding vitamin D to tadalafil 5 mg treatment is useful in patients with erectile dysfunction and vitamin D deficiency?
Urol Int
. 2021
;31
:1
–6
.25.
Carvalheira
AA
, Pereira
NM
, Maroco
J
, Forjaz
V
. Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation
. J Sex Med
. 2012
;9
(9
):2361
–9
. .26.
Russo
GI
, Di Mauro
M
, Cocci
A
, Cacciamani
G
, Cimino
S
, Serefoglu
EC
, Consulting “Dr Google” for sexual dysfunction: a contemporary worldwide trend analysis
. Int J Impot Res
. 2019
;32
(4
):455
–61
.27.
Bechara
A
, Casabé
A
, De Bonis
W
, Ciciclia
PG
. Twelve-month efficacy and safety of low-intensity shockwave therapy for erectile dysfunction in patients who do not respond to phosphodiesterase type 5 inhibitors
. Sex Med
. 2016
;4
(4
):e225
–32
. .28.
Sramkova
T
, Motil
I
, Jarkovsky
J
, Sramkova
K
. Erectile dysfunction treatment using focused linear low-intensity extracorporeal shockwaves: single-blind, sham-controlled, randomized clinical trial
. Urol Int
. 2020
;104
(5–6
):417
–24
. .29.
Sokolakis
I
, Hatzichristodoulou
G
. Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials
. Int J Impot Res
. 2019
;31
(3
):177
–94
. .30.
Porst
H
. Review of the current status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie’s Disease (PD), and sexual rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients
. Sex Med Rev
. 2021
;9
(1
):93
–122
. .31.
Kessler
A
, Sollie
S
, Challacombe
B
, Briggs
K
, van Hemelrijck
M
. The global prevalence of erectile dysfunction: a review
. BJU Int
. 2019
;124
(4
):587
–99
. .32.
Hermann
M
, Flammer
A
, Lüscher
TF
. Nitric oxide in hypertension
. J Clin Hypertens
. 2006
;8
(12 Suppl 4
):17
–29
. .33.
Baumhäkel
M
, Schlimmer
N
, Kratz
M
, Hackett
G
, Hacket
G
, Jackson
G
, Cardiovascular risk, drugs and erectile function: a systematic analysis
. Int J Clin Pract
. 2011
;65
(3
):289
–98
. .34.
Lu
Z
, Lin
G
, Reed-Maldonado
A
, Wang
C
, Lee
Y-C
, Lue
TF
. Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis
. Eur Urol
. 2017
;71
(2
):223
–33
. .35.
Kitrey
ND
, Gruenwald
I
, Appel
B
, Shechter
A
, Massarwa
O
, Vardi
Y
. Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: a double-blind, sham controlled study
. J Urol
. 2016
;195
(5
):1550
–5
. .36.
Lei
Q
, Wang
D
, Liu
C
, Ji
Z
, Yan
S
. Comparison of the efficacy and safety of low-intensity extracorporeal shock wave therapy versus on-demand sildenafil for erectile dysfunction
. Transl Androl Urol
. 2021
;10
(2
):860
–8
. .37.
Steers
WD
. Neural pathways and central sites involved in penile erection: neuroanatomy and clinical implications
. Neurosci Biobehav Rev
. 2000
;24
(5
):507
–16
. .© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
